Literature DB >> 9875321

Localization and fine mapping of antigenic sites on the nucleocapsid protein N of porcine reproductive and respiratory syndrome virus with monoclonal antibodies.

J J Meulenberg1, A P van Nieuwstadt, A van Essen-Zandbergen, J N Bos-de Ruijter, J P Langeveld, R H Meloen.   

Abstract

The purpose of this study was to analyze the antigenic structure of the nucleocapsid protein N of the Lelystad virus isolate of porcine reproductive and respiratory syndrome virus (PRRSV) and to identify antigenic differences between this prototype European isolate and other North American isolates. To do this, we generated a panel of monoclonal antibodies (mAbs) directed against the N protein of Lelystad virus and tested them in competition assays with other N-specific mAbs described previously (Drew et al., 1995; Nelson et al., 1993; van Nieuwstadt et al., 1996). Four different competition groups of mAbs were identified. Pepscan analysis with solid-phase dodecapeptides was used to identify specific antigenic regions in the N protein that were bound by the mAbs. In this pepscan analysis, we found that the mAb of the first competition group reacted with linear peptides whose core sequences consisted of amino acids 2-12 (site A), the mAbs of the second group reacted with peptides whose core sequences consisted of amino acids 25-30 (site B), and the mAb of the third group reacted with peptides whose core sequences consisted of amino acids 40-46 (site C). However, the fourth group of mAbs binding to an antigenic region, provisionally designated as domain D, reacted very weakly or did not react at all with solid-phase dodecapeptides. To further characterize the structure of the epitopes in domain D, we produced chimeric constructs composed of the N protein sequences of Lelystad virus and another arterivirus lactate dehydrogenase-elevating virus, which was used because its N protein has similarity in amino acid sequence and hydropathicity profile but does not react with our mAbs. When the mAbs specific to domain D were tested for binding to the chimeric N proteins expressed by Semliki Forest virus, we found that the regions between amino acids 51-67 and amino acids 80-90 are involved in the formation or are part of the epitopes in domain D. Therefore, we conclude that the N protein contains four distinct antigenic regions. The epitopes mapped to sites A-C are linear, whereas the epitopes mapped to domain D are more conformation dependent or discontinuous. Sites A and C contain epitopes that are conserved in European but not in North American isolates; site B contains epitopes that are conserved in European and North American isolates; and site D contains epitopes that are either conserved or not conserved in European and North American isolates. The antigenic regions identified here might be important for the development of diagnostic test for PRRSV in particular tests that discriminate between different antigenic types of PRRSV.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9875321     DOI: 10.1006/viro.1998.9436

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  21 in total

1.  Disulfide linkages mediating nucleocapsid protein dimerization are not required for porcine arterivirus infectivity.

Authors:  Rong Zhang; Chunyan Chen; Zhi Sun; Feifei Tan; Jinshan Zhuang; Debin Tian; Guangzhi Tong; Shishan Yuan
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

2.  Antigenic importance of the carboxy-terminal beta-strand of the porcine reproductive and respiratory syndrome virus nucleocapsid protein.

Authors:  S Wootton; G Koljesar; L Yang; K J Yoon; D Yoo
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

3.  Identification of a novel B cell epitope on the nucleocapsid protein of porcine reproductive and respiratory syndrome virus by phage display.

Authors:  Tong-Qing An; Yan-Jun Zhou; Hua-Ji Qiu; Guang-Zhi Tong; Yun-Feng Wang; Jin-Xia Liu; Jin-Yu Yang
Journal:  Virus Genes       Date:  2005-08       Impact factor: 2.332

4.  Nucleocapsid protein-based enzyme-linked immunosorbent assay for detection and differentiation of antibodies against European and North American porcine reproductive and respiratory syndrome virus.

Authors:  Torsten Seuberlich; Jon-Duri Tratschin; Barbara Thür; Martin A Hofmann
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

5.  Epitope mapping porcine reproductive and respiratory syndrome virus by phage display: the nsp2 fragment of the replicase polyprotein contains a cluster of B-cell epitopes.

Authors:  M B Oleksiewicz; A Bøtner; P Toft; P Normann; T Storgaard
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

6.  Identification of epitopes on nonstructural protein 7 of porcine reproductive and respiratory syndrome virus recognized by monoclonal antibodies using phage-display technology.

Authors:  Heng Wang; Rongchang Liu; Weidong Zhang; Lingshuang Sun; Zhangyong Ning; Fangxiao Ji; Jin Cui; Guihong Zhang
Journal:  Virus Genes       Date:  2017-06-08       Impact factor: 2.332

7.  Homo-oligomerization of the porcine reproductive and respiratory syndrome virus nucleocapsid protein and the role of disulfide linkages.

Authors:  Sarah K Wootton; Dongwan Yoo
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

8.  Mapping of antigenic sites on the nucleocapsid protein of the severe acute respiratory syndrome coronavirus.

Authors:  Yuxian He; Yusen Zhou; Hao Wu; Zhihua Kou; Shuwen Liu; Shibo Jiang
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

9.  Phosphorylation of the porcine reproductive and respiratory syndrome virus nucleocapsid protein.

Authors:  Sarah K Wootton; Raymond R R Rowland; Dongwan Yoo
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Defining the antigenic structure of human GM-CSF and its implications for receptor interaction and therapeutic treatments.

Authors:  Marcos Oggero; Ronald Frank; Marina Etcheverrigaray; Ricardo Kratje
Journal:  Mol Divers       Date:  2004       Impact factor: 2.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.